Needle biopsy may one day spare breast cancer patients from surgery
NCT ID NCT02455791
First seen Oct 01, 2025 · Last updated Apr 24, 2026 · Updated 24 times
Summary
This study tests whether a less invasive ultrasound-guided needle biopsy can accurately tell if breast cancer has been completely eliminated by chemotherapy, compared to standard surgery. About 43 women with aggressive breast cancer types (triple negative or HER2-positive) who have completed chemotherapy will receive both a needle biopsy and surgery. The goal is to see if the needle biopsy is reliable enough to potentially avoid surgery in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.